402 related articles for article (PubMed ID: 30888555)
1. Identification of key genes relevant to the prognosis of ER-positive and ER-negative breast cancer based on a prognostic prediction system.
Xiao B; Hang J; Lei T; He Y; Kuang Z; Wang L; Chen L; He J; Zhang W; Liao Y; Sun Z; Li L
Mol Biol Rep; 2019 Apr; 46(2):2111-2119. PubMed ID: 30888555
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
Wu JR; Zhao Y; Zhou XP; Qin X
Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
[TBL] [Abstract][Full Text] [Related]
3. A 63 signature genes prediction system is effective for glioblastoma prognosis.
Zhang Y; Xu J; Zhu X
Int J Mol Med; 2018 Apr; 41(4):2070-2078. PubMed ID: 29393370
[TBL] [Abstract][Full Text] [Related]
4. Network-based approach to identify prognosis-related genes in tamoxifen-treated patients with estrogen receptor-positive breast cancer.
Wang Y; Gong X; Zhang Y
Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34406386
[TBL] [Abstract][Full Text] [Related]
5. Identification of differentially expressed genes between triple and non-triple-negative breast cancer using bioinformatics analysis.
Zhai Q; Li H; Sun L; Yuan Y; Wang X
Breast Cancer; 2019 Nov; 26(6):784-791. PubMed ID: 31197620
[TBL] [Abstract][Full Text] [Related]
6. Screening of the prognostic targets for breast cancer based co-expression modules analysis.
Liu H; Ye H
Mol Med Rep; 2017 Oct; 16(4):4038-4044. PubMed ID: 28731166
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the miRNA-mRNA-lncRNA network in human estrogen receptor-positive and estrogen receptor-negative breast cancer based on TCGA data.
Xiao B; Zhang W; Chen L; Hang J; Wang L; Zhang R; Liao Y; Chen J; Ma Q; Sun Z; Li L
Gene; 2018 Jun; 658():28-35. PubMed ID: 29518546
[TBL] [Abstract][Full Text] [Related]
8. Identification of key candidate genes, pathways and related prognostic values in ER-negative/HER2-negative breast cancer by bioinformatics analysis.
Shao N; Yuan K; Zhang Y; Yun Cheang T; Li J; Lin Y
J BUON; 2018; 23(4):891-901. PubMed ID: 30358191
[TBL] [Abstract][Full Text] [Related]
9. Clinical Value of miR-101-3p and Biological Analysis of its Prospective Targets in Breast Cancer: A Study Based on The Cancer Genome Atlas (TCGA) and Bioinformatics.
Li CY; Xiong DD; Huang CQ; He RQ; Liang HW; Pan DH; Wang HL; Wang YW; Zhu HW; Chen G
Med Sci Monit; 2017 Apr; 23():1857-1871. PubMed ID: 28416776
[TBL] [Abstract][Full Text] [Related]
10. Identification of Methylation Markers and Differentially Expressed Genes with Prognostic Value in Breast Cancer.
Wu J; Zhang Y; Li M
J Comput Biol; 2019 Dec; 26(12):1394-1408. PubMed ID: 31290690
[TBL] [Abstract][Full Text] [Related]
11. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
[TBL] [Abstract][Full Text] [Related]
12. Identification of Genes with Prognostic Value in the Breast Cancer Microenvironment Using Bioinformatics Analysis.
Ren H; Hu D; Mao Y; Su X
Med Sci Monit; 2020 Apr; 26():e920212. PubMed ID: 32251269
[TBL] [Abstract][Full Text] [Related]
13. A 44-gene set constructed for predicting the prognosis of clear cell renal cell carcinoma.
Wang Y; Wang Y; Liu F
Int J Mol Med; 2018 Dec; 42(6):3105-3114. PubMed ID: 30272265
[TBL] [Abstract][Full Text] [Related]
14. Identification of Differentially Expressed Genes (DEGs) Relevant to Prognosis of Ovarian Cancer by Use of Integrated Bioinformatics Analysis and Validation by Immunohistochemistry Assay.
Zhang L; Sun L; Zhang B; Chen L
Med Sci Monit; 2019 Dec; 25():9902-9912. PubMed ID: 31871312
[TBL] [Abstract][Full Text] [Related]
15. Screening of Prognostic Factors in Early-Onset Breast Cancer.
Yu Z; He Q; Xu G
Technol Cancer Res Treat; 2020; 19():1533033819893670. PubMed ID: 32028860
[TBL] [Abstract][Full Text] [Related]
16. Network-based approach to identify prognostic biomarkers for estrogen receptor-positive breast cancer treatment with tamoxifen.
Liu R; Guo CX; Zhou HH
Cancer Biol Ther; 2015; 16(2):317-24. PubMed ID: 25756514
[TBL] [Abstract][Full Text] [Related]
17. Identification of prognostic biomarkers for breast cancer based on miRNA and mRNA co-expression network.
Yao Y; Liu R; Gao C; Zhang T; Qi L; Liu G; Zhang W; Wang X; Li J; Li J; Sun C
J Cell Biochem; 2019 Sep; 120(9):15378-15388. PubMed ID: 31037764
[TBL] [Abstract][Full Text] [Related]
18. A qualitative transcriptional signature to reclassify histological grade of ER-positive breast cancer patients.
Li J; Jiang W; Liang Q; Liu G; Dai Y; Zheng H; Yang J; Cai H; Zheng G
BMC Genomics; 2020 Apr; 21(1):283. PubMed ID: 32252627
[TBL] [Abstract][Full Text] [Related]
19. Identification of a 6-gene signature for the survival prediction of breast cancer patients based on integrated multi-omics data analysis.
Mo W; Ding Y; Zhao S; Zou D; Ding X
PLoS One; 2020; 15(11):e0241924. PubMed ID: 33170908
[TBL] [Abstract][Full Text] [Related]
20. Identification of Critical Genes and Five Prognostic Biomarkers Associated with Colorectal Cancer.
Huang Z; Yang Q; Huang Z
Med Sci Monit; 2018 Jul; 24():4625-4633. PubMed ID: 29973580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]